Testing effectiveness (Phase 2)Study completedNCT04417088
What this trial is testing
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
Who this might be right for
Recurrent Glioblastoma
InSightec 28